Blab Tech
GapMinder Leads Seed Funding Round for Croatian Healthtech Startup Lasken AI
On July 21 2026, venture‑capital firm GapMinder announced it was the lead investor in a seed‑stage financing round for Croatian health‑technology company Lasken AI. The round was co‑invested by Fil Rouge Capital, a Zagreb‑based fund that focuses on early‑stage technology businesses in the region.
GapMinder, founded in 2017 and headquartered in Amsterdam, has built a portfolio of 61 technology companies across Eastern Europe. The firm’s investment mandate, as described in its public filings, targets seed and Series A rounds in technology‑driven companies in the EBRD regions, including Romania, Bulgaria, Croatia, Moldova, Serbia and Slovenia. According to industry data, GapMinder typically invests between US$1 million and US$5 million in each deal.
Fil Rouge Capital, established in 2014, concentrates on pre‑seed, seed and Series A investments in consumer products, information technology, SaaS and e‑commerce. The firm has a track record of backing high‑growth startups in Croatia and the surrounding area.
Lasken AI describes itself as an AI‑powered feed that helps teams in healthcare and care‑delivery organisations stay informed, discover the right partners and act faster. The platform aggregates and structures external information that is often fragmented and unstructured, making it easier for healthcare providers to track evolving services, focus areas and team changes.
The seed round, led by GapMinder with participation from Fil Rouge Capital, did not disclose the amount raised. The funding will be used to accelerate product development, expand the user base and strengthen the company’s presence in the Croatian market.
The announcement comes amid a broader trend of increased venture capital activity in Eastern European health‑tech. In recent years, investors have shown growing interest in startups that apply artificial intelligence to improve healthcare workflows, patient engagement and partner discovery.
Lasken AI’s focus on AI‑driven information aggregation positions it within a niche that has attracted attention from both investors and industry stakeholders. The company’s platform is designed to address the challenge of keeping healthcare teams up‑to‑date with rapidly changing services and partnerships.
GapMinder’s involvement signals confidence in Lasken AI’s technology and business model. The firm’s history of investing in early‑stage companies across the region suggests it sees potential for the startup to scale beyond Croatia.
Fil Rouge Capital’s participation further underscores the local appetite for health‑tech innovation. The firm’s portfolio includes several other Croatian startups that have secured seed and Series A funding in recent months.
While the exact valuation of Lasken AI was not announced, the seed round is expected to provide the company with the capital needed to expand its product roadmap, hire additional engineering and sales staff, and pursue strategic partnerships with larger healthcare providers.
The funding round also highlights the role of regional venture funds in supporting technology startups that address local market needs while maintaining the potential for cross‑border expansion.
As of the announcement, Lasken AI remains a privately held company. No additional regulatory filings or public disclosures have been made regarding the round. The company has not yet announced a public launch date for new features or an expansion plan.
The investment is part of a broader strategy by GapMinder and Fil Rouge Capital to deepen their presence in the health‑tech sector. Both firms have indicated that they will continue to seek opportunities in early‑stage companies that leverage AI to solve complex problems in healthcare and related industries.
In summary, the seed round led by GapMinder and co‑invested by Fil Rouge Capital provides Lasken AI with the resources to advance its AI‑powered feed platform. The deal reflects growing investor confidence in Eastern European health‑tech startups and the potential for AI solutions to improve healthcare operations.
The outcome of this funding round will be monitored closely by investors and industry analysts as the company moves toward product scaling and potential market expansion beyond Croatia.
GapMinder, founded in 2017 and headquartered in Amsterdam, has built a portfolio of 61 technology companies across Eastern Europe. The firm’s investment mandate, as described in its public filings, targets seed and Series A rounds in technology‑driven companies in the EBRD regions, including Romania, Bulgaria, Croatia, Moldova, Serbia and Slovenia. According to industry data, GapMinder typically invests between US$1 million and US$5 million in each deal.
Fil Rouge Capital, established in 2014, concentrates on pre‑seed, seed and Series A investments in consumer products, information technology, SaaS and e‑commerce. The firm has a track record of backing high‑growth startups in Croatia and the surrounding area.
Lasken AI describes itself as an AI‑powered feed that helps teams in healthcare and care‑delivery organisations stay informed, discover the right partners and act faster. The platform aggregates and structures external information that is often fragmented and unstructured, making it easier for healthcare providers to track evolving services, focus areas and team changes.
The seed round, led by GapMinder with participation from Fil Rouge Capital, did not disclose the amount raised. The funding will be used to accelerate product development, expand the user base and strengthen the company’s presence in the Croatian market.
The announcement comes amid a broader trend of increased venture capital activity in Eastern European health‑tech. In recent years, investors have shown growing interest in startups that apply artificial intelligence to improve healthcare workflows, patient engagement and partner discovery.
Lasken AI’s focus on AI‑driven information aggregation positions it within a niche that has attracted attention from both investors and industry stakeholders. The company’s platform is designed to address the challenge of keeping healthcare teams up‑to‑date with rapidly changing services and partnerships.
GapMinder’s involvement signals confidence in Lasken AI’s technology and business model. The firm’s history of investing in early‑stage companies across the region suggests it sees potential for the startup to scale beyond Croatia.
Fil Rouge Capital’s participation further underscores the local appetite for health‑tech innovation. The firm’s portfolio includes several other Croatian startups that have secured seed and Series A funding in recent months.
While the exact valuation of Lasken AI was not announced, the seed round is expected to provide the company with the capital needed to expand its product roadmap, hire additional engineering and sales staff, and pursue strategic partnerships with larger healthcare providers.
The funding round also highlights the role of regional venture funds in supporting technology startups that address local market needs while maintaining the potential for cross‑border expansion.
As of the announcement, Lasken AI remains a privately held company. No additional regulatory filings or public disclosures have been made regarding the round. The company has not yet announced a public launch date for new features or an expansion plan.
The investment is part of a broader strategy by GapMinder and Fil Rouge Capital to deepen their presence in the health‑tech sector. Both firms have indicated that they will continue to seek opportunities in early‑stage companies that leverage AI to solve complex problems in healthcare and related industries.
In summary, the seed round led by GapMinder and co‑invested by Fil Rouge Capital provides Lasken AI with the resources to advance its AI‑powered feed platform. The deal reflects growing investor confidence in Eastern European health‑tech startups and the potential for AI solutions to improve healthcare operations.
The outcome of this funding round will be monitored closely by investors and industry analysts as the company moves toward product scaling and potential market expansion beyond Croatia.
